ONCO Stock Analysis: Buy, Sell, or Hold?
ONCO - Onconetix, Inc. Common Stock
$1.28
-0.66 (-34.02%)
▼
5d:
+112.73%
30d:
+91.33%
90d:
-10.49%
WAIT
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 11, 2026
Get Alerted When ONCO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ONCO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ONCO shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ONCO is currently trading at $1.28, which is considered extended relative to its 30-day fair value range of $0.17 to $1.51.
Technical Outlook: Technically, ONCO is in a strong downtrend. Immediate support is located at $0.45, while resistance sits at $6.73. Short-term momentum is weak, with the stock down 34.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+363.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ONCO is in a strong downtrend. Immediate support is located at $0.45, while resistance sits at $6.73. Short-term momentum is weak, with the stock down 34.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+363.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.17 -
$1.51
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
40.5%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (45/100)
- BEARISH: Downward momentum (-34.0%)
- BULLISH: Trading 363.9% below Wall St target ($9.00)
Fair Price Analysis
30-Day Fair Range
$0.17 -
$1.51
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$0.45
Resistance Level
$6.73
Current Trend
Strong Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Wall Street Target
$9.00
(+363.9%)
Revenue Growth (YoY)
-57.4%
Share & Embed Analysis
Last updated: March 30, 2026 9:55 AM ET
Data refreshes hourly during market hours. Next update: 10:55 AM
Data refreshes hourly during market hours. Next update: 10:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ONCO showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 65 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 54 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$132 | 49 HOLD |
